BRIMICA

This brand name is authorized in Austria, Australia, Estonia, Spain, Croatia, Ireland, Lithuania, New Zealand, Poland, Romania, Turkey

Active ingredients

The drug BRIMICA contains a combination of these active pharmaceutical ingredients (APIs):

1 Aclidinium
UNII UQW7UF9N91 - ACLIDINIUM BROMIDE

Aclidinium is a competitive, selective muscarinic receptor antagonist (also known as an anticholinergic), with a longer residence time at the M3 receptors than the M2 receptors. M3 receptors mediate contraction of airway smooth muscle. Inhaled aclidinium acts locally in the lungs to antagonise M3 receptors of airway smooth muscle and induce bronchodilation.

Read about Aclidinium
2 Eformoterol
UNII W34SHF8J2K - FORMOTEROL FUMARATE

Formoterol is a predominantly selective β2-stimulator. Formoterol has bronchodilator activity in patients with reversible obstructive airway diseases. In humans formoterol is effective in the prophylaxis of bronchospasm induced by methacholine challenge.

Read about Eformoterol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R03AL05 Formoterol and aclidinium bromide R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AL Adrenergics in combination with anticholinergics
Discover more medicines within R03AL05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 10565C
Country: EE Ravimiamet Identifier(s): 1669697, 1669709, 1727838
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 114963001
Country: IE Health Products Regulatory Authority Identifier(s): 36866
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1075093, 1075094, 1080830
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 17993
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100332911
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W69356001
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699832550016, 8699832550023, 8699832550030

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.